Literature DB >> 23659671

Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation.

Scott T Youngquist1, James T Niemann, Atman P Shah, Joseph L Thomas, John P Rosborough.   

Abstract

To compare the early postarrest inflammatory cytokine response between animals administered amiodarone (AMIO) and lidocaine (LIDO) intra-arrest during resuscitation from ventricular fibrillation (VF). Domestic swine (n=32) were placed under general anesthesia and instrumented before spontaneous VF was induced by balloon occlusion of the left anterior descending coronary artery. After 7 min of VF, standard ACLS resuscitation was performed and animals were randomized to either bolus AMIO (5 mg/kg, n=13) or LIDO (1 mg/kg, n=14) for recurrent or refractory VF. A non-antiarrhythmic (n=5) was also used for comparison. Following return of spontaneous circulation (ROSC), tumor necrosis factor (TNF)-α levels were drawn at 30 and 60 min. Groups were comparable with respect to prearrest hemodynamics and resuscitation variables. In the postarrest period, the LIDO and non-antiarrhythmic group demonstrated virtually identical TNF-α response trajectories. However, TNF-α levels were significantly higher in AMIO- than LIDO-treated animals at 30 min (geometric mean 539 versus 240 pg/mL, 2.2-fold higher, 95% confidence interval [CI] 1.3-3.8-fold higher, P=0.003) and at 60 min (geometric mean 570 versus 204 pg/mL, 2.8-fold higher, 95% CI 1.1-7.0-fold higher, P=0.03). Significant differences in the postarrest TNF-α levels were observed between animals treated with AMIO as compared to those treated with LIDO. Improved rates of ROSC seen with AMIO may come at the expense of a heightened proinflammatory state in the postcardiac arrest period.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23659671      PMCID: PMC3665303          DOI: 10.1089/jir.2012.0123

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  18 in total

1.  The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β.

Authors:  Xu Wu; Yan Lu; Yuanlin Dong; Guohua Zhang; Yiying Zhang; Zhipeng Xu; Deborah J Culley; Gregory Crosby; Edward R Marcantonio; Rudolph E Tanzi; Zhongcong Xie
Journal:  Neurobiol Aging       Date:  2010-12-28       Impact factor: 4.673

Review 2.  Post cardiac arrest syndrome: a review of therapeutic strategies.

Authors:  Dion Stub; Stephen Bernard; Stephen J Duffy; David M Kaye
Journal:  Circulation       Date:  2011-04-05       Impact factor: 29.690

3.  Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.

Authors:  Paul Dorian; Dan Cass; Brian Schwartz; Richard Cooper; Robert Gelaznikas; Aiala Barr
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

4.  Significance of elevated serum interleukin-8 in patients resuscitated after cardiopulmonary arrest.

Authors:  T Ito; D Saitoh; K Fukuzuka; T Kiyozumi; M Kawakami; T Sakamoto; Y Okada
Journal:  Resuscitation       Date:  2001-10       Impact factor: 5.262

5.  The effects of intra-operative amiodarone loading on the systemic inflammatory response syndrome induced by cardiopulmonary bypass.

Authors:  Ali Rahman; Handan Akbulut; Mustafa Kemal Bayar; Mehmet Ozden; Oktay Burma; Ayhan Uysal
Journal:  Anadolu Kardiyol Derg       Date:  2009-08

6.  Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.

Authors:  Haruyasu Ito; Koh Ono; Ryousuke Nishio; Shigetake Sasayama; Akira Matsumori
Journal:  Cytokine       Date:  2002-02-21       Impact factor: 3.861

7.  Amiodarone stimulates interleukin-6 production in cultured human thyrocytes, exerting cytotoxic effects on thyroid follicles in suspension culture.

Authors:  K Nakajima; K Yamazaki; E Yamada; Y Kanaji; S Kosaka; K Sato; K Takano
Journal:  Thyroid       Date:  2001-02       Impact factor: 6.568

8.  Tumor necrosis factor-alpha is associated with early postresuscitation myocardial dysfunction.

Authors:  James T Niemann; Daniel Garner; Roger J Lewis
Journal:  Crit Care Med       Date:  2004-08       Impact factor: 7.598

9.  Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes.

Authors:  Yu-Hsun Kao; Yao-Chang Chen; Chen-Chuan Cheng; Ting-I Lee; Yi-Jen Chen; Shih-Ann Chen
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

Review 10.  Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?

Authors:  Christophe Adrie; Ivan Laurent; Mehran Monchi; Alain Cariou; Jean-François Dhainaou; Christian Spaulding
Journal:  Curr Opin Crit Care       Date:  2004-06       Impact factor: 3.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.